Social Norms and Antihypertensive Medication Adherence
Hypertension, Medication Adherence

About this trial
This is an interventional health services research trial for Hypertension focused on measuring Hypertension, Medication, Adherence
Eligibility Criteria
Inclusion Criteria:
- Person has been diagnosed with essential hypertension for at least a year (no new or recently diagnosed hypertensive patients)
- Person is currently taking no more than 2 medications
- Person has taken the same anti-hypertensive medication for at least a year (no recent changes in medication)
- Person reports not being adherent to anti-hypertensive medication
- Speaks English or Spanish, currently insured
- Has access to the Internet
- Willing to participate in social media, able to go to West Kendall Baptist Hospital
- Available for the next 8 months
Exclusion Criteria:
- Persons with Secondary hypertension
- Persons with coronary heart disease, cerebrovascular disorders or atrial fibrillation,
- Persons with rubber allergy, or bedridden, wheelchair bound.
- Persons who have had a stroke or myocardial infarction within the previous 6 months, are pregnant, or have any serious chronic disease will also be excluded from the study.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Placebo Comparator
Group Contingency Management
Individual Contingency Management
Control Arm
During the intervention phase, the Group Contingency Management (GCM) arm will continue to take their hypertensive medication for the four-month period and will receive a randomized phone call once a month to obtain a pill count and a home blood pressure monitoring reading using the HBPM. Participants in the GCM arm will receive a payment after each phone call, dependent on their medication adherence assessment. The GCM arm will also receive an additional payment based on their group's medication adherence.The intervention administered is the Financial Reward and Social Norms.
During the intervention phase, those in the Individual Contingency Management (ICM) arm will also continue to take their hypertensive medication for the four-month period but will receive a payment after each phone call, dependent on their medication adherence assessment.The intervention administered is the Financial Reward.
During the intervention phase, those in the control arm will be asked to continue to take their hypertensive medication for the four-month period and will receive a randomized phone call once a month to obtain a pill count and a blood pressure reading using the HBPM. Those in the control arm will only be paid for their participation in the study regardless of medication adherence assessment.